BRCA1-IRIS Overexpression Promotes Formation of Aggressive Breast Cancers

INTRODUCTION: Women with HER2(+) or triple negative/basal-like (TN/BL) breast cancers succumb to their cancer rapidly due, in part to acquired Herceptin resistance and lack of TN/BL-targeted therapies. BRCA1-IRIS is a recently discovered, 1399 residue, BRCA1 locus alternative product, which while sh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Shimizu, Yoshiko, Luk, Hugh, Horio, David, Miron, Penelope, Griswold, Michael, Iglehart, Dirk, Hernandez, Brenda, Killeen, Jeffrey, ElShamy, Wael M.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3325250/
https://ncbi.nlm.nih.gov/pubmed/22511931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0034102
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados